Medical Marketing & Media - News, Features & Insights
WEBThe digital marketing landscape is changing but the challenge for marketers remains: how to develop campaigns that deliver relevant, actionable content to hyper-targeted audience profiles. The latest on medical marketing. News, analysis, features, and insights for leaders, marketers, and creatives involved in promoting and commercializing ...
MM+M Agency 100 2024
WEBWelcome to the 2024 MM+M Agency 100. In an era where therapeutically transformative breakthroughs and tech-fueled disruption are the norm, the MM+M Agency 100 remains the definitive guide to the ever-evolving world of medical marketing agencies. Between the Top 100 and Ones to Watch, this year’s edition shines the spotlight on 109 medical ...
In-Depth - MM+M - Medical Marketing and Media
WEBPipeline Report 2023: Game on for blockbusters, novel MOAs and practice-changing drugs. The industry awaits a number of readouts and approvals for drugs that address market gaps and enrich treatment landscapes — with huge sales potential to boot. Healthcare Marketers Trend Report 2024: A techno twist The MM+M/Swoop 2024 Healthcare Marketers ...
About MM+M - MM+M - Medical Marketing and Media
WEBMM+M, first published in 1966 as Medical Marketing + Media, is the media brand of record for pharmaceutical marketing and commercialization, delivering the most balanced and relevant coverage of its subject matter. The 57-year-old business title produces an essential mix of online breaking news and analysis combined with monthly print features — timely, objective, original editorial content ...
MM+M Magazine - MM+M - Medical Marketing and Media
WEBLatest Issue: August/September 2024 The AI personalization dilemma Will AI kill the health influencer? In a point of care state of mind 'Granfluencers' in
Cyberattacks plague the health industry. Critics call feds’ response ...
WEB1 day ago · Cyberattacks complicate mundane and complex tasks alike, said Nate Couture, chief information security officer at the University of Vermont Health Network, which was struck by a ransomware attack in 2020. “We can’t mix a chemo cocktail by eye,” he said, referring to cancer treatments, at a June event in Washington, D.C.
Rx Rundown: MaxCyte, Roche, and more
WEB1 day ago · Roche won approval from the FDA for an injectable version of its multiple sclerosis therapy Ocrevus. FDA approves Novartis Kisqali to reduce risk of recurrence in people with HR+/HER2- early breast cancer. Lilly’s EBGLYSS (lebrikizumab-lbkz) won approval for adults and children 12 years and older …
MM+M debuts 2022 Agency 100 - Medical Marketing + Media
WEBJan 31, 2022 · MM+M has launched the survey for the 2022 version of its Agency 100 ranking of North America’s medical marketing agencies. The survey, through which MM+M compiles the data that informs its Top 100 selections, can be accessed here.. This year’s Agency 100 coverage will be published across MM+M’s digital channels on June 7 and in the June print edition of the magazine.
2022 MM+M Awards: All the Winners
WEBThe MM+M Awards is celebrating its 19th year of recognizing healthcare marketing and media that is the most creative and effective in the industry. MM+M Staff. October 6, 2022. 10:30 pm. To view the digital edition of the 2022 MM+M Awards Book of the Night, click here. I attended the MM+M Awards for the first time in October 2014.
The 2021 MM+M Awards: The Shortlist - MM+M - Medical …
WEBJul 8, 2021 · See all the finalists for this year's MM+M Awards, which will be held October 7 at Cipriani Wall Street as a hybrid live and virtual event.